Loading…
Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort
ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both p...
Saved in:
Published in: | Journal of bone and mineral research 2019-06, Vol.34 (6), p.1074-1085 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533 |
---|---|
cites | cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533 |
container_end_page | 1085 |
container_issue | 6 |
container_start_page | 1074 |
container_title | Journal of bone and mineral research |
container_volume | 34 |
creator | Feurer, Elodie Kan, Casina Croset, Martine Sornay‐Rendu, Elisabeth Chapurlat, Roland |
description | ABSTRACT
Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research. |
doi_str_mv | 10.1002/jbmr.3685 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2188205795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2188205795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhi1ERUPhwB9AlriA1G299vqLWxKaFpRSqZQDJ2vizNINu-ti71L67-s0hQMSl_nQPHo1My8hr0p2VDLGjzerLh4JZeQTMiklF0WlTPmUTJgxVcEqUe6T5yltGGNKKvWM7AtmBLOaT8jvJfgfNNR0mlLwDQxN6OkMh1vEnn7BFv1A5030Y5tH_XfaNZefp4lCv6az0CM9h5QO6dUY-_AL4-HDYBHBD2PE9J5-gAFyHzo6XCO9WJwsv9F5uA5xeEH2amgTvnzMB-Tr4uRqflYsL04_zqfLwgtjZAFW6xUDqJXKhYCq1rxGu66tVdqUK6UU4Np68GCRWwRW6Ry8kFrLWgpxQN7udG9i-DliGlzXJI9tCz2GMTleGsOZ1FZm9M0_6Cbkw_J2jnMlpeJGqEy921E-hpQi1u4mNh3EO1cyt7XDbe1wWzsy-_pRcVx1uP5L_vl_Bo53wG3T4t3_ldyn2fnlg-Q9F8WTaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2265562836</pqid></control><display><type>article</type><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><source>Oxford Journals Online</source><creator>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</creator><creatorcontrib>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</creatorcontrib><description>ABSTRACT
Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.3685</identifier><identifier>PMID: 30830972</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Absorptiometry ; Age ; AGING ; Bone mass ; BONE QCT/MICROCT ; Bone turnover ; DISEASES AND DISORDERS OF/RELATED TO BONE ; DXA ; Fractures ; Hormone replacement therapy ; miRNA ; Morbidity ; OSTEOPOROSIS ; Post-menopause ; Serum levels</subject><ispartof>Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1074-1085</ispartof><rights>2019 American Society for Bone and Mineral Research</rights><rights>2019 American Society for Bone and Mineral Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</citedby><cites>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30830972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feurer, Elodie</creatorcontrib><creatorcontrib>Kan, Casina</creatorcontrib><creatorcontrib>Croset, Martine</creatorcontrib><creatorcontrib>Sornay‐Rendu, Elisabeth</creatorcontrib><creatorcontrib>Chapurlat, Roland</creatorcontrib><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT
Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</description><subject>Absorptiometry</subject><subject>Age</subject><subject>AGING</subject><subject>Bone mass</subject><subject>BONE QCT/MICROCT</subject><subject>Bone turnover</subject><subject>DISEASES AND DISORDERS OF/RELATED TO BONE</subject><subject>DXA</subject><subject>Fractures</subject><subject>Hormone replacement therapy</subject><subject>miRNA</subject><subject>Morbidity</subject><subject>OSTEOPOROSIS</subject><subject>Post-menopause</subject><subject>Serum levels</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kU1vEzEQhi1ERUPhwB9AlriA1G299vqLWxKaFpRSqZQDJ2vizNINu-ti71L67-s0hQMSl_nQPHo1My8hr0p2VDLGjzerLh4JZeQTMiklF0WlTPmUTJgxVcEqUe6T5yltGGNKKvWM7AtmBLOaT8jvJfgfNNR0mlLwDQxN6OkMh1vEnn7BFv1A5030Y5tH_XfaNZefp4lCv6az0CM9h5QO6dUY-_AL4-HDYBHBD2PE9J5-gAFyHzo6XCO9WJwsv9F5uA5xeEH2amgTvnzMB-Tr4uRqflYsL04_zqfLwgtjZAFW6xUDqJXKhYCq1rxGu66tVdqUK6UU4Np68GCRWwRW6Ry8kFrLWgpxQN7udG9i-DliGlzXJI9tCz2GMTleGsOZ1FZm9M0_6Cbkw_J2jnMlpeJGqEy921E-hpQi1u4mNh3EO1cyt7XDbe1wWzsy-_pRcVx1uP5L_vl_Bo53wG3T4t3_ldyn2fnlg-Q9F8WTaQ</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Feurer, Elodie</creator><creator>Kan, Casina</creator><creator>Croset, Martine</creator><creator>Sornay‐Rendu, Elisabeth</creator><creator>Chapurlat, Roland</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201906</creationdate><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><author>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Absorptiometry</topic><topic>Age</topic><topic>AGING</topic><topic>Bone mass</topic><topic>BONE QCT/MICROCT</topic><topic>Bone turnover</topic><topic>DISEASES AND DISORDERS OF/RELATED TO BONE</topic><topic>DXA</topic><topic>Fractures</topic><topic>Hormone replacement therapy</topic><topic>miRNA</topic><topic>Morbidity</topic><topic>OSTEOPOROSIS</topic><topic>Post-menopause</topic><topic>Serum levels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feurer, Elodie</creatorcontrib><creatorcontrib>Kan, Casina</creatorcontrib><creatorcontrib>Croset, Martine</creatorcontrib><creatorcontrib>Sornay‐Rendu, Elisabeth</creatorcontrib><creatorcontrib>Chapurlat, Roland</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feurer, Elodie</au><au>Kan, Casina</au><au>Croset, Martine</au><au>Sornay‐Rendu, Elisabeth</au><au>Chapurlat, Roland</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2019-06</date><risdate>2019</risdate><volume>34</volume><issue>6</issue><spage>1074</spage><epage>1085</epage><pages>1074-1085</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><abstract>ABSTRACT
Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30830972</pmid><doi>10.1002/jbmr.3685</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0884-0431 |
ispartof | Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1074-1085 |
issn | 0884-0431 1523-4681 |
language | eng |
recordid | cdi_proquest_miscellaneous_2188205795 |
source | Oxford Journals Online |
subjects | Absorptiometry Age AGING Bone mass BONE QCT/MICROCT Bone turnover DISEASES AND DISORDERS OF/RELATED TO BONE DXA Fractures Hormone replacement therapy miRNA Morbidity OSTEOPOROSIS Post-menopause Serum levels |
title | Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A59%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20Association%20Between%20Select%20Circulating%20miRNAs%20and%20Bone%20Mass,%20Turnover,%20and%20Fractures:%20Data%20From%20the%20OFELY%20Cohort&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=Feurer,%20Elodie&rft.date=2019-06&rft.volume=34&rft.issue=6&rft.spage=1074&rft.epage=1085&rft.pages=1074-1085&rft.issn=0884-0431&rft.eissn=1523-4681&rft_id=info:doi/10.1002/jbmr.3685&rft_dat=%3Cproquest_cross%3E2188205795%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2265562836&rft_id=info:pmid/30830972&rfr_iscdi=true |